URBANI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 479
EU - Europa 396
AS - Asia 162
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.039
Nazione #
US - Stati Uniti d'America 478
IT - Italia 115
IE - Irlanda 105
SE - Svezia 61
SG - Singapore 55
HK - Hong Kong 45
CN - Cina 41
UA - Ucraina 31
FI - Finlandia 26
RU - Federazione Russa 16
VN - Vietnam 12
GB - Regno Unito 11
DE - Germania 8
FR - Francia 7
BE - Belgio 4
CH - Svizzera 4
PL - Polonia 4
KR - Corea 3
CZ - Repubblica Ceca 2
AZ - Azerbaigian 1
CA - Canada 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
JO - Giordania 1
LB - Libano 1
NL - Olanda 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.039
Città #
Dublin 105
Chandler 101
San Mateo 63
Perugia 61
Hong Kong 45
Singapore 44
Boardman 31
Santa Clara 20
Beijing 18
Medford 17
Princeton 17
Andover 16
Altamura 15
Ann Arbor 15
Jacksonville 14
Lawrence 14
Dong Ket 12
Houston 12
Foligno 10
Helsinki 9
Wilmington 9
Des Moines 6
Norwalk 6
Saint Petersburg 6
Woodbridge 5
Ashburn 4
Deruta 4
New York 4
San Paolo di Civitate 4
Dallas 3
Prata Di Pordenone 3
Redwood City 3
Seoul 3
Shanghai 3
Brussels 2
Espoo 2
Redmond 2
Rome 2
West Jordan 2
Zaventem 2
Auburn Hills 1
Baku 1
Battipaglia 1
Brno 1
Den Haag 1
Johannesburg 1
Kocaeli 1
Lonate Ceppino 1
Los Angeles 1
Mogliano 1
Moscow 1
Munich 1
Orlando 1
Ottawa 1
Padova 1
Philadelphia 1
San Benedetto Del Tronto 1
San Diego 1
Spello 1
Spoleto 1
Taipei 1
Totale 735
Nome #
Innate immunity against hematological malignancies 105
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 98
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 74
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 71
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 69
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 63
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 62
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 59
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 56
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 55
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 52
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 49
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 46
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 45
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 45
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 40
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 39
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 30
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 25
Totale 1.083
Categoria #
all - tutte 4.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 3 0 5 2 10 19 6 6
2020/2021132 7 8 6 7 38 11 7 3 17 6 8 14
2021/2022230 3 49 2 5 15 0 6 56 0 20 45 29
2022/2023313 19 66 4 22 21 27 0 16 116 1 17 4
2023/2024143 7 17 5 3 0 3 42 4 6 3 29 24
2024/202597 5 26 8 23 35 0 0 0 0 0 0 0
Totale 1.083